"10.1371_journal.pone.0042728","none","2012-08-13T00:00:00Z","Gian-Andri Thun; Ilaria Ferrarotti; Medea Imboden; Thierry Rochat; Margaret Gerbase; Florian Kronenberg; Pierre-Olivier Bridevaux; Elisabeth Zemp; Michele Zorzetto; Stefania Ottaviani; Erich W Russi; Maurizio Luisetti; Nicole M Probst-Hensch","Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland; Center for Diagnosis of Inherited Alpha1-antitrypsin Deficiency, Institute for Respiratory Disease, IRCCS San Matteo Hospital Foundation, University of Pavia, Pavia, Italy; Division of Pulmonary Medicine, University Hospital of Geneva, Geneva, Switzerland; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria; Pulmonary Division, University Hospital of Zurich, Zurich, Switzerland","Conceived and designed the experiments: TR EWR ML NPH. Performed the experiments: GAT IF MI MZ SO. Analyzed the data: GAT IF MI TR NPH. Contributed reagents/materials/analysis tools: MG FK POB EZ. Wrote the paper: GAT NPH. Contributed to the interpretation of the data: IF MI TR NPH .","This study was funded by SUVA, Talecris Biotherapeutics GmbH, Abbott Diagnostics and Kedrion S.p.A. The Center for Diagnosis of Inherited Alpha1-antitrypsin Deficiency in Pavia is supported by grants from Talecris Biotherapeutics GmbH and Kedrion S.p.A. NPH has received an unrestricted research grant from Talecris GmbH. The grant money was applied to covering part of the salary costs for GAT. IF has received educational and consultancy fees, research grant (eALTA Award), and travel support from Talecris Biotherapeutics GmbH and Kedrion S.p.A. TR has received fees for consulting once in 2011 by Talecris Biotherapeutics GmbH. SO has received travel support from Grifols International S.A. and consultancy fees by Kedrion S.p.A. ML travels to European Respiratory Society and American Thoracic Society congresses have been funded by Talecris Biotherapeutics GmbH, has performed paid lectures for Kedrion S.p.A., has obtained research funds by Talecris Biotherapeutics GmbH, as well as funds for staff members. None of the companies was involved in defining specific aims, conduct of data analysis, data interpretation or decision to publish. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","08","Gian-Andri Thun","GAT",13,TRUE,4,5,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
